Terry M Nolan

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. pmc The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children
    Stephen B Lambert
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute, Royal Children s Hospital, and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
    Respir Res 9:11. 2008
  2. pmc Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults
    James M McCaw
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, 3010, Australia
    BMC Infect Dis 12:345. 2012
  3. pmc Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception
    Lyndal Bond
    MRC CSO Social and Public Health Sciences Unit, Glasgow, UK
    BMC Public Health 11:943. 2011
  4. pmc Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks
    James M McCaw
    Murdoch Childrens Research Institute, University of Melbourne, Parkville, Vic, Australia
    BMC Infect Dis 10:166. 2010
  5. ncbi request reprint DTPa-HBV-IPV vaccine for primary vaccination of infants
    Terry Nolan
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
    J Paediatr Child Health 43:587-92. 2007
  6. ncbi request reprint A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants
    Terry Nolan
    Murdoch Children s Research Institute and School of Population Health, The University of Melbourne, Australia
    Vaccine 25:8487-99. 2007
  7. doi request reprint Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
    Terry Nolan
    School of Population Health, University of Melbourne and Murdoch Children s Research Institute, Carlton, Melbourne, Victoria 3010, Australia
    Pediatrics 121:508-16. 2008
  8. doi request reprint Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
    Terry M Nolan
    Murdoch Childrens Research Institute, and the Melbourne School of Population Health, University of Melbourne, Carlton, Victoria, Australia
    Vaccine 26:4160-7. 2008
  9. doi request reprint Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
    Terry Nolan
    Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
    Vaccine 26:6383-91. 2008
  10. doi request reprint Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine
    Terry Nolan
    Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
    Vaccine 27:2410-3. 2009

Detail Information

Publications33

  1. pmc The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children
    Stephen B Lambert
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute, Royal Children s Hospital, and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
    Respir Res 9:11. 2008
    ..Despite their ubiquity, there is a lack of interdisciplinary epidemiologic and economic research that has collected primary impact data, particularly associated with indirect costs, from families during ARIs in children...
  2. pmc Household transmission of respiratory viruses - assessment of viral, individual and household characteristics in a population study of healthy Australian adults
    James M McCaw
    Murdoch Children s Research Institute and Melbourne School of Population Health, The University of Melbourne, Parkville, Victoria, 3010, Australia
    BMC Infect Dis 12:345. 2012
    ..Household transmission of influenza-like illness (ILI) may vary with viral and demographic characteristics. We examined the effect of these factors in a population-based sample of adults with ILI...
  3. pmc Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception
    Lyndal Bond
    MRC CSO Social and Public Health Sciences Unit, Glasgow, UK
    BMC Public Health 11:943. 2011
    ..The aim of this study was to examine the utility of subjective risk perception and decision-making theories to provide a better understanding of the differences between immunisers' and non-immunisers' health beliefs and behaviours...
  4. pmc Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networks
    James M McCaw
    Murdoch Childrens Research Institute, University of Melbourne, Parkville, Vic, Australia
    BMC Infect Dis 10:166. 2010
    ..We report on a pilot study designed to assess three different methods (one retrospective, two prospective) for obtaining contact data relevant to the determination of these mixing patterns...
  5. ncbi request reprint DTPa-HBV-IPV vaccine for primary vaccination of infants
    Terry Nolan
    Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
    J Paediatr Child Health 43:587-92. 2007
    ....
  6. ncbi request reprint A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants
    Terry Nolan
    Murdoch Children s Research Institute and School of Population Health, The University of Melbourne, Australia
    Vaccine 25:8487-99. 2007
    ..Hib-MenCY-TT administered according to the current US Hib vaccine schedule has the potential to induce protective antibodies against Hib and meningococcal-CY disease in infants and toddlers...
  7. doi request reprint Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
    Terry Nolan
    School of Population Health, University of Melbourne and Murdoch Children s Research Institute, Carlton, Melbourne, Victoria 3010, Australia
    Pediatrics 121:508-16. 2008
    ..This study evaluated the safety, tolerability, and immunogenicity of live attenuated influenza vaccine administered concurrently with measles-mumps-rubella vaccine and varicella vaccine to healthy children 12 to 15 months of age...
  8. doi request reprint Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
    Terry M Nolan
    Murdoch Childrens Research Institute, and the Melbourne School of Population Health, University of Melbourne, Carlton, Victoria, Australia
    Vaccine 26:4160-7. 2008
    ..A secondary objective was to assess the cross-reactivity of immune responses to two variant clade 2 H5N1 strains...
  9. doi request reprint Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
    Terry Nolan
    Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
    Vaccine 26:6383-91. 2008
    ..Our objective was to evaluate the safety and immunogenicity of a prototype inactivated, aluminium adjuvanted, split-virus, clade 1 H5N1 vaccine (A/Vietnam/1194/2004/NIBRG-14) in infants and children aged > or =6 months to < 9 years...
  10. doi request reprint Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccine
    Terry Nolan
    Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
    Vaccine 27:2410-3. 2009
    ....
  11. doi request reprint Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children
    Terry Nolan
    Vaccine and Immunisation Research Group at the Murdoch Children s Research Institute and the Melbourne School of Population Health, University of Melbourne, Victoria 3010, Australia
    Influenza Other Respi Viruses 3:315-25. 2009
    ..Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax; CSL Limited, Parkville, Australia) in children aged 6 months to <9 years...
  12. doi request reprint Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial
    Terry Nolan
    Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
    JAMA 303:37-46. 2010
    ..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children...
  13. doi request reprint The Australian model of immunization advice and vaccine funding
    Terry M Nolan
    Australian Technical Advisory Group on Immunisation, Head School of Population Health, University of Melbourne, Murdoch, Melbourne, Carlton 3010, Australia
    Vaccine 28:A76-83. 2010
    ....
  14. doi request reprint Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine
    Terry Nolan
    Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and School of Population Health, University of Melbourne, Victoria, Australia
    Pediatr Infect Dis J 30:190-6. 2011
    ..Neisseria meningitidis serogroups B, C, and Y cause most meningococcal disease in industrialized countries. A Haemophilus influenzae type b-meningococcal serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) was evaluated...
  15. ncbi request reprint Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age
    Terry Nolan
    School of Population Health, University of Melbourne, Victoria 3010, Australia
    Pediatrics 118:e602-9. 2006
    ....
  16. ncbi request reprint Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine
    T Nolan
    Murdoch Children s Research Institute, The University of Melbourne, VIC 3010, Australia
    Vaccine 23:14-20. 2004
    ..5% of booster recipients experienced >50-mm local swelling at the site of DTPa vaccination. We conclude that DTPa-HBV-IPV/Hib is safe and immunogenic for primary vaccination, and that Hib-specific memory is induced by primary vaccination...
  17. ncbi request reprint Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine
    Terry Nolan
    The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
    Vaccine 21:281-9. 2002
    ..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies...
  18. ncbi request reprint Paediatric slow-speed non-traffic fatalities: Victoria, Australia, 1985-1995
    P Robinson
    Public Health Branch, Department of Human Services, Victoria, Australia
    Accid Anal Prev 29:731-7. 1997
    ..These findings suggest some countermeasures, including the separation of vehicle driveways from children's play areas, and object vicinity ultrasonic warning devices for vehicles...
  19. pmc Randomised controlled trial of biofeedback training in persistent encopresis with anismus
    T Nolan
    Melbourne University Department of Paediatrics, Royal Children s Hospital, Parkville Victoria, Australia
    Arch Dis Child 79:131-5. 1998
    ..Biofeedback training can be used to teach children to abolish this abnormal contraction...
  20. ncbi request reprint Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccination
    S R Skinner
    Clinical Epidemiology and Biostatistics Unit, Royal Children s Hospital, Parkville, Victoria
    Aust N Z J Public Health 24:298-304. 2000
    ..This study aimed to evaluate a specifically designed hepatitis B education/promotion curriculum package as part of a successful hepatitis B vaccination delivery system to adolescents...
  21. ncbi request reprint A combined liquid Hib (PRP-OMP), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: uncontrolled preliminary clinical trial of immunogenicity and reactogenicity
    T Nolan
    Melbourne University Department of Paediatrics, Royal Children s Hospital, Australia
    Vaccine 16:2085-9. 1998
    ..This study has provided preliminary evidence for both the safety and immunogenicity of the pentavalent vaccine given as a course at 2, 4, 6 and 18 months...
  22. ncbi request reprint A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity
    T Nolan
    Clinical Epidemiology and Biostatistics Unit, Melbourne University Department of Paediatrics at the Royal Children s Hospital and Murdoch Children s Research Institute, Vic, 3052, Parkville, Australia
    Vaccine 19:2127-37. 2001
    ..A regimen of a birth dose of hepatitis B vaccine followed by pentavalent vaccine at 2, 4, 6 and 18 months was not countered by any clinically significant decrease in seroresponses...
  23. ncbi request reprint Immunogenicity and reactogenicity associated with an 18-month booster dose of a new diphtheria-tetanus-whole cell pertussis vaccine
    T Nolan
    Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia
    J Paediatr Child Health 34:346-8. 1998
    ..To establish safety and immunogenicity of a reformulated whole cell pertussis based diphtheria-tetanus-pertussis vaccine (DTPw) at the 18-month booster stage following a 2, 4, and 6-month primary immunization course...
  24. ncbi request reprint Vaccine preventable diseases and immunisations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriers
    L Bond
    Dept of Paediatrics, University of Melbourne, Royal Children s Hospital, Parkville
    Aust N Z J Public Health 22:441-6. 1998
    ..This study found that many mothers were balancing the risks of immunising with the risks of not immunising and this must be taken into account, along with factors such as difficulties in obtaining immunisations...
  25. ncbi request reprint Measles-mumps-rubella and hepatitis B vaccination uptake in adolescents: a survey in metropolitan Melbourne
    S R Skinner
    Royal Children s Hospital, Melbourne, Vic
    Med J Aust 168:546-9. 1998
    ..To measure the uptake of preadolescent measles-mumps-rubella (MMR) and adolescent hepatitis B vaccinations and assess the influence of certain demographic factors on the uptake of these vaccines...
  26. ncbi request reprint Immunisation uptake, services required and government incentives for users of formal day care
    L Bond
    Centre for Adolescent Health, Royal Children s Hospital, Parkville, Victoria
    Aust N Z J Public Health 23:368-76. 1999
    ..To determine immunisation uptake in children attending formal day care prior to the introduction of certificates (state) and parent incentives (federal), and to document parent and child carers' attitudes to these strategies...
  27. pmc Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile
    James M McCaw
    Vaccine and Immunisation Research Group, Melbourne School of Population Health, University of Melbourne and Murdoch Childrens Research Institute, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Med J Aust 191:136-7. 2009
    ..Targeted post-exposure prophylaxis represents a more efficient use of the stockpile than treatment alone...
  28. ncbi request reprint A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years
    H Marshall
    Department of Paediatrics, Children s Youth and Women s Health Service and University of Adelaide, SA, Australia
    Vaccine 24:6120-8. 2006
    ..This combined DTPa-IPV vaccine has a similar reactogenicity profile to DTPa, is immunogenic when given as a booster dose at 4-6 years of age, and has no impact on the immunogenicity of a co-administered second dose of MMR vaccine...
  29. ncbi request reprint Quality of hospital care for seriously ill children in less-developed countries
    T Nolan
    Department of Paediatrics, University of Melbourne and Murdock Children's Research Institute, Royal Children's Hospital, Parkville, Australia
    Lancet 357:106-10. 2001
    ..Possible targets for improvement include initial triage, emergency care, assessment, inpatient treatment, and monitoring. Priority targets for individual hospitals may be determined by assessing each hospital...
  30. pmc Risk-factors for meningococcal disease in Victoria, Australia, in 1997
    P Robinson
    Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute/Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Victoria
    Epidemiol Infect 127:261-8. 2001
    ..Besides confirming some previously identified risk factors, this is the first time that snoring and speech problems have been identified as risk factors for meningococcal disease...
  31. ncbi request reprint Laboratory enhanced surveillance for meningococcal disease in Victoria
    P Robinson
    Department of Human Services, Victoria, Melbourne, Australia
    J Paediatr Child Health 37:S7-12. 2001
    ..To describe the epidemiological and microbiological characteristics and notification patterns of invasive meningococcal disease (IMD) in Victoria between 1990 and 1999...
  32. ncbi request reprint Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy
    C M Bolton
    Department of Anaesthesia and Pain Management, University of Melbourne, Royal Children s Hospital, Murdoch Children s Research Institute, Flemington Road, Parkville, Melbourne 3052, Australia
    Br J Anaesth 99:699-703. 2007
    ..It has been suggested that at moderate doses (0.5 mg kg(-1)), metoclopramide is also an effective agent. No study has been performed comparing the efficacy of an anti-serotinergic agent and moderate-dose metoclopramide...
  33. pmc Twelve year outcomes following bacterial meningitis: further evidence for persisting effects
    K Grimwood
    Department of Paediatrics, University of Melbourne, Melbourne, Australia
    Arch Dis Child 83:111-6. 2000
    ..To determine whether intellectual and cognitive impairments observed seven years following early childhood bacterial meningitis persist into adolescence...